Please login to the form below

Not currently logged in
Email:
Password:

Teva appoints UK & Ireland general manager

Promotes UK chief operating officer Kim Innes

Teva Kim InnesTeva UK has promoted chief operating officer Kim Innes to general manager of its UK and Ireland business, succeeding Richard Daniell.

Innes brings almost 25 years of industry experience to the role, during which time she served a two-year term as chair of the British Generic Manufacturers' Association.

She became head of Teva's generics business unit in the UK in 2006, before taking on her most recent position as chief operating officer in which she played a key role in the company's acquisition of Actavis Generics.

Innes said: “I am excited to be leading this great organisation at what is a transformational time for both Teva as a company and the pharmaceutical industry as a whole.

“We have an extremely talented group of people here in the UK and Ireland and I am confident that we will continue to maintain our leadership position while keeping an absolute focus on our patients and customers.”

10th October 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...